{"id":"sinovac-rabies-vaccine","safety":{"commonSideEffects":[{"rate":"null","effect":"Pain, redness, or swelling at the injection site"}]},"_chembl":{"chemblId":"CHEMBL2107909","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This vaccine contains inactivated rabies virus particles that are unable to cause disease but can still trigger an immune response. The immune system recognizes the virus particles as foreign and mounts a response to eliminate them, producing antibodies that can neutralize the rabies virus in the future.","oneSentence":"The Sinovac rabies vaccine works by stimulating the body's immune system to produce antibodies against the rabies virus.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:34:44.361Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Pre-exposure prophylaxis against rabies"}]},"trialDetails":[{"nctId":"NCT07416110","phase":"PHASE3","title":"Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine","status":"NOT_YET_RECRUITING","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2026-03-04","conditions":"Rabies (Healthy Volunteers)","enrollment":912},{"nctId":"NCT07357545","phase":"PHASE3","title":"Immunogenicity and Safety Assessment of Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2021-08-27","conditions":"Rabies (Healthy Volunteers)","enrollment":2040},{"nctId":"NCT07055893","phase":"PHASE3","title":"Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen","status":"NOT_YET_RECRUITING","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2026-03-01","conditions":"Rabies (Healthy Volunteers)","enrollment":390},{"nctId":"NCT07055880","phase":"PHASE2","title":"Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell)","status":"NOT_YET_RECRUITING","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2025-07-28","conditions":"Rabies","enrollment":120},{"nctId":"NCT07055295","phase":"PHASE3","title":"Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen","status":"NOT_YET_RECRUITING","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2026-03-01","conditions":"Rabies","enrollment":390},{"nctId":"NCT02985320","phase":"PHASE1, PHASE2","title":"Studies of the Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2016-10","conditions":"Poliomyelitis","enrollment":708}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Sinovac rabies vaccine","genericName":"Sinovac rabies vaccine","companyName":"Sinovac Biotech Co., Ltd","companyId":"sinovac-biotech-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"The Sinovac rabies vaccine works by stimulating the body's immune system to produce antibodies against the rabies virus. Used for Pre-exposure prophylaxis against rabies.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}